{"id":"https://openalex.org/W2588058970","doi":"https://doi.org/10.1093/ndt/gfw190.38","title":"MP381CHARACTERISTICS OF RESPONDERS AND NON-RESPONDERS TO TREATMENT WITH SUCROFERRIC OXYHYDROXIDE: A POST HOC ANALYSIS OF A PHASE 3 STUDY","display_name":"MP381CHARACTERISTICS OF RESPONDERS AND NON-RESPONDERS TO TREATMENT WITH SUCROFERRIC OXYHYDROXIDE: A POST HOC ANALYSIS OF A PHASE 3 STUDY","alternate_titles":[],"publication_year":2016,"publication_date":"2016-05-01","ids":{"openalex":"https://openalex.org/W2588058970","doi":"https://doi.org/10.1093/ndt/gfw190.38","mag":"2588058970"},"language":"en","primary_location":{"id":"doi:10.1093/ndt/gfw190.38","doi":"https://doi.org/10.1093/ndt/gfw190.38","is_oa":false,"landing_page_url":"https://doi.org/10.1093/ndt/gfw190.38","pdf_url":null,"source":{"id":"https://openalex.org/S186113128","display_name":"Nephrology Dialysis Transplantation","issn_l":"0931-0509","issn":["0931-0509","1460-2385"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nephrology Dialysis Transplantation","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2588058970"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5107960647","display_name":"J\u00fcrgen Floege","orcid":"https://orcid.org/0000-0001-7102-6150","observed_orcids":["https://orcid.org/0000-0001-7102-6150"]},"institutions":[{"id":"https://openalex.org/I4210120689","display_name":"Universit\u00e4tsklinikum Aachen","ror":"https://ror.org/02gm5zw39","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210120689"]},{"id":"https://openalex.org/I887968799","display_name":"RWTH Aachen University","ror":"https://ror.org/04xfq0f34","country_code":"DE","type":"education","lineage":["https://openalex.org/I887968799"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"J\u00fcrgen Floege","raw_affiliation_strings":["RWTH University Hospital Aachen, Department of Nephrology and Clinical Immunology, Aachen, GERMANY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RWTH University Hospital Aachen, Department of Nephrology and Clinical Immunology, Aachen, GERMANY","institution_ids":["https://openalex.org/I4210120689","https://openalex.org/I887968799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030580194","display_name":"Stuart Michael Sprague","orcid":"https://orcid.org/0000-0002-3330-0179","observed_orcids":["https://orcid.org/0000-0002-3330-0179"]},"institutions":[{"id":"https://openalex.org/I1339509835","display_name":"Endeavor Health","ror":"https://ror.org/04tpp9d61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1339509835"]},{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stuart Sprague","raw_affiliation_strings":["NorthShore University Health System, University of Chicago, Division of Nephrology and Hypertension, Evanston, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NorthShore University Health System, University of Chicago, Division of Nephrology and Hypertension, Evanston, IL","institution_ids":["https://openalex.org/I1339509835","https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064512017","display_name":"Anjay Rastogi","orcid":"https://orcid.org/0000-0002-8117-6010","observed_orcids":["https://orcid.org/0000-0002-8117-6010"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anjay Rastogi","raw_affiliation_strings":["University of California, Department of Medicine, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Department of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046643853","display_name":"Markus Ketteler","orcid":"https://orcid.org/0000-0002-7214-1895","observed_orcids":["https://orcid.org/0000-0002-7214-1895"]},"institutions":[{"id":"https://openalex.org/I4210129277","display_name":"Klinikum Coburg","ror":"https://ror.org/02d1rkr63","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210129277"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Markus Ketteler","raw_affiliation_strings":["Coburg Clinic and KfH-Dialysis Center, Division of Nephrology, Coburg, GERMANY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Coburg Clinic and KfH-Dialysis Center, Division of Nephrology, Coburg, GERMANY","institution_ids":["https://openalex.org/I4210129277"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046429359","display_name":"Adrian Constantin Covic","orcid":"https://orcid.org/0000-0002-9985-2486","observed_orcids":["https://orcid.org/0000-0002-9985-2486"]},"institutions":[{"id":"https://openalex.org/I304011483","display_name":"Grigore T. Popa University of Medicine and Pharmacy","ror":"https://ror.org/03hd30t45","country_code":"RO","type":"education","lineage":["https://openalex.org/I304011483"]}],"countries":["RO"],"is_corresponding":false,"raw_author_name":"Adrian Covic","raw_affiliation_strings":["Gr. T. Popa\u2019 University of Medicine and Pharmacy, Department of Internal Medicine, Iasi, ROMANIA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gr. T. Popa\u2019 University of Medicine and Pharmacy, Department of Internal Medicine, Iasi, ROMANIA","institution_ids":["https://openalex.org/I304011483"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058132352","display_name":"Viatcheslav G. Rakov","orcid":"https://orcid.org/0009-0004-0324-9239","observed_orcids":["https://orcid.org/0009-0004-0324-9239"]},"institutions":[{"id":"https://openalex.org/I4210102083","display_name":"Vifor Pharma (Switzerland)","ror":"https://ror.org/0185z7g17","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210102083"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Viatcheslav Rakov","raw_affiliation_strings":["Vifor Pharma, Global Medical Affairs, Glattbrugg, SWITZERLAND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vifor Pharma, Global Medical Affairs, Glattbrugg, SWITZERLAND","institution_ids":["https://openalex.org/I4210102083"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045033537","display_name":"Sylvain Larroque","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102083","display_name":"Vifor Pharma (Switzerland)","ror":"https://ror.org/0185z7g17","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210102083"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Sylvain Larroque","raw_affiliation_strings":["Vifor Pharma, Clinical Development and Medical Affairs, Glattbrugg, SWITZERLAND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vifor Pharma, Clinical Development and Medical Affairs, Glattbrugg, SWITZERLAND","institution_ids":["https://openalex.org/I4210102083"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046497650","display_name":"Pablo E. P\u00e9rgola","orcid":"https://orcid.org/0000-0002-5876-894X","observed_orcids":["https://orcid.org/0000-0002-5876-894X"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pablo Pergola","raw_affiliation_strings":["University of Texas Health Sciences Center, Department of Medicine, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Health Sciences Center, Department of Medicine, San Antonio, TX","institution_ids":["https://openalex.org/I165951966"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3474,"currency":"EUR","value_usd":3926},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"suppl_1","first_page":"i466","last_page":"i466"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10516","display_name":"Parathyroid Disorders and Treatments","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10516","display_name":"Parathyroid Disorders and Treatments","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10291","display_name":"Dialysis and Renal Disease Management","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12876","display_name":"Potassium and Related Disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sucroferric-oxyhydroxide","display_name":"sucroferric oxyhydroxide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/sevelamer-carbonate","display_name":"sevelamer carbonate","score":0.9620000123977661},{"id":"https://openalex.org/keywords/hyperphosphatemia","display_name":"hyperphosphatemia","score":0.984000027179718},{"id":"https://openalex.org/keywords/dialysis-patients","display_name":"dialysis patients","score":0.7760000228881836},{"id":"https://openalex.org/keywords/ckd-mbd","display_name":"chronic kidney disease-mineral and bone disorder","score":0.949999988079071},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.6399999856948853},{"id":"https://openalex.org/keywords/serum-phosphorus","display_name":"serum phosphorus","score":0.7179999947547913},{"id":"https://openalex.org/keywords/intact-parathyroid-hormone","display_name":"intact parathyroid hormone","score":0.9359999895095825},{"id":"https://openalex.org/keywords/fgf23","display_name":"fibroblast growth factor 23","score":0.8799999952316284},{"id":"https://openalex.org/keywords/pill-burden","display_name":"medication burden","score":0.781000018119812},{"id":"https://openalex.org/keywords/iron-based-phosphate-binder","display_name":"iron-based phosphate binder","score":0.7799999713897705},{"id":"https://openalex.org/keywords/dose-titration","display_name":"dose titration","score":0.6690000295639038},{"id":"https://openalex.org/keywords/predictors-of-treatment-response","display_name":"predictors of treatment response","score":0.5899999737739563},{"id":"https://openalex.org/keywords/post-hoc-analysis","display_name":"post hoc analysis","score":0.4519999921321869}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.928254246711731},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.7939376831054688},{"id":"https://openalex.org/C2992886853","wikidata":"https://www.wikidata.org/wiki/Q18381816","display_name":"Post hoc","level":2,"score":0.6043435335159302},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4476470351219177},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.44015973806381226},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35474300384521484},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/ndt/gfw190.38","doi":"https://doi.org/10.1093/ndt/gfw190.38","is_oa":false,"landing_page_url":"https://doi.org/10.1093/ndt/gfw190.38","pdf_url":null,"source":{"id":"https://openalex.org/S186113128","display_name":"Nephrology Dialysis Transplantation","issn_l":"0931-0509","issn":["0931-0509","1460-2385"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nephrology Dialysis Transplantation","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2801462336","https://openalex.org/W4384923578","https://openalex.org/W2117639138","https://openalex.org/W3127716455","https://openalex.org/W3037500181","https://openalex.org/W7127045254","https://openalex.org/W3033098738","https://openalex.org/W4415426493","https://openalex.org/W2803700831","https://openalex.org/W3111123358"],"abstract_inverted_index":{"Introduction":[0],"and":[1,8,38,106,112,118,139,152,177,200,257,259,263],"Aims:":[2],"Identifying":[3],"the":[4,36,50,98,161,171,175,211,251,266,287],"characteristics":[5,40,105,144],"of":[6,28,109,133],"responders":[7,124,187,206,247,262,275],"non-responders":[9,140,189,208,232,249,264,277],"to":[10,49,67,197,242],"phosphate":[11,52],"binder":[12],"therapy":[13],"for":[14,21,77,274],"hyperphosphatemia":[15],"may":[16],"help":[17],"optimise":[18],"treatment":[19,43,147,220,280],"selection":[20],"dialysis":[22,158],"patients.":[23],"This":[24],"post":[25],"hoc":[26],"analysis":[27,100],"data":[29],"from":[30,195,225,240],"a":[31,78,92,153,243],"Phase":[32],"3":[33],"study":[34],"evaluated":[35],"clinical":[37],"biochemical":[39],"associated":[41,145],"with":[42,146,210],"response":[44,148],"in":[45,91,123,160,165,170,186,192,205,215,227,231,250,261,265,278,286],"patients":[46,63,88],"either":[47],"randomized":[48,65],"iron-based":[51],"binder,":[53],"sucroferric":[54],"oxyhydroxide":[55],"(SFOH),":[56],"or":[57,72],"sevelamer":[58],"carbonate":[59],"(SEV).":[60],"Methods:":[61],"1059":[62],"were":[64,89,121,149,184,202],"2:1":[66],"SFOH":[68,162,176,252,288],"1.0-3.0":[69],"g/day":[70,75],"(N=710)":[71],"SEV":[73,178,267],"2.4-14.4":[74],"(N=349)":[76],"12-week":[79],"dose":[80],"titration,":[81],"followed":[82],"by":[83],"12":[84],"weeks\u2019":[85],"maintenance.":[86],"Eligible":[87],"enrolled":[90],"28-week":[93],"safety":[94],"extension":[95],"study.":[96],"From":[97],"full":[99],"set":[101],"population":[102],"(N=1041),":[103],"baseline":[104,180,196,226,241],"serum":[107,130,181,193],"levels":[108,132,183,223,238],"phosphorus,":[110],"iPTH":[111,222],"FGF23":[113,237],"at":[114,125,233,254],"baseline,":[115],"Week":[116,119,126,234],"24":[117,199,256],"52":[120,127,201,235],"analysed":[122],"(patients":[128],"achieving":[129],"phosphorus":[131,182,194],"1.78":[134],"mmol/l":[135],"[\u22645.5":[136],"mg/dl];":[137],"n=302)":[138],"(n=195).":[141],"Results:":[142],"Baseline":[143],"older":[150],"age":[151],"longer":[154],"time":[155],"period":[156],"on":[157],"(P<0.05":[159],"group).":[163],"Changes":[164],"CKD-MBD":[166],"parameters":[167],"are":[168],"shown":[169],"Table.":[172],"In":[173,218],"both":[174,219,279],"groups,":[179,221,281],"lower":[185,273],"vs":[188,207,248,276,291],"(P<0.05).":[190,236],"Decreases":[191],"Weeks":[198,255],"also":[203,272],"greater":[204,244],"(P<0.05),":[209],"greatest":[212],"reductions":[213],"observed":[214],"SFOH-treated":[216],"responders.":[217],"decreased":[224,239],"responders,":[228],"but":[229,282],"increased":[230],"extent":[245],"among":[246],"group":[253,289],"52,":[258],"similarly":[260],"group.":[268],"Pill":[269],"burden":[270],"was":[271],"only":[283],"statistically":[284],"significant":[285],"(3.6":[290],"4.0":[292],"tablets/day;":[293],"P<0.05).":[294]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2588058970","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2017-02-24T00:00:00"}
